Additive Interaction of Metabolic Syndrome and Chronic Kidney Disease on Cardiac Hypertrophy, and Risk of Cardiovascular Disease in Hypertension | Zendy

Yoshio Iwashima | Zendy; T. Horio | Zendy; Kei Kamide | Zendy; Takeshi Tokudome | Zendy; Fumiki Yoshihara | Zendy; Satoaki Nakamura | Zendy; Toshio Ogihara | Zendy; Hiromi Rakugi | Zendy; Yuhei Kawano | Zendy

Open Access

Additive Interaction of Metabolic Syndrome and Chronic Kidney Disease on Cardiac Hypertrophy, and Risk of Cardiovascular Disease in Hypertension

Author(s) -

Yoshio Iwashima,

T. Horio,

Kei Kamide,

Takeshi Tokudome,

Fumiki Yoshihara,

Satoaki Nakamura,

Toshio Ogihara,

Hiromi Rakugi,

Yuhei Kawano

Publication year - 2009

Publication title -

american journal of hypertension

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.009

H-Index - 136

eISSN - 1941-7225

pISSN - 0895-7061

DOI - 10.1038/ajh.2009.253

Subject(s) - medicine , kidney disease , metabolic syndrome , hazard ratio , cardiology , left ventricular hypertrophy , odds ratio , blood pressure , confidence interval , proportional hazards model , obesity

Recent epidemiologic analyses have demonstrated a link between the metabolic syndrome (MetS) and chronic kidney disease (CKD). We examined the association between MetS, CKD, and left ventricular hypertrophy (LVH), and prospectively investigated the predictive value of the combination of MetS and CKD for cardiovascular disease (CVD) in essential hypertension.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research